Placebo News and Research

RSS

Neurotransmitter responsible for brain arousal plays vital role in early sensory perceptions

Being aware of our surroundings is a fundamental aspect of our existence. But what in our biological makeup determines how we access and interpret the endless stream of information around us?

10 Jul 2018

Human trial identifies common blood pressure medication as safe, effective therapy for diabetes

Researchers at the University of Alabama at Birmingham Comprehensive Diabetes Center have discovered a safe and effective novel therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset Type 1 diabetes by promoting the patient's own beta cell function and insulin production -- the first such discovery to target diabetes in this manner.

9 Jul 2018

Step towards an HIV/AIDS vaccine

There has been a four decades long challenge to develop a vaccine against the deadly HIV virus that causes AIDS. Last Saturday the research bore fruit when a team of scientists announced that a trial drug has shown immune response in humans and also protected laboratory monkeys from HIV infection.

9 Jul 2018

Study offers new hope for people with disabling Dupuytren's disease

Researchers at the Kennedy Institute and Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, working with clinicians at NHS Lothian, have found that injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules results in the reduction of the cell characteristics responsible for progression of Dupuytren's disease.

9 Jul 2018

Violent tendencies could be curbed by brain stimulation

According to a new study, a brain intervention could stop a perverse desire to be physically or sexually violent in some individuals.

4 Jul 2018

Study finds link between testosterone and men's preference for status goods

A recent study conducted by a research team around Hilke Plassmann, the INSEAD Chaired Professor of Decision Neuroscience & Brain and Spine Institute, a principal investigator in the Social Affective Neuroscience Team at the ICM, David Dubois, Associate Professor of Marketing at INSEAD and Gideon Nave, Assistant Professor of Marketing at The Wharton School & the Wharton Neuroscience Initiative shows that testosterone, the male sex hormone, increased men's preference for status goods compared to goods of similar perceived quality but seen as lower in status.

4 Jul 2018

Antioxidants do not improve sperm quality

Researchers have found that despite studies that claim that antioxidants are good for sperm production, a new study has shown that there is no such benefit.

4 Jul 2018

Preventive treatment for recurrent pregnancy loss proved ineffective in large study

An immune response to pregnancy (in which the uterus rejects the embryo or fetus) is said to explain a large number of otherwise "unexplained" miscarriages.

3 Jul 2018

Testosterone has measurable effect on a man's preference for brands

Some men, it seems, can't get enough of luxury goods like European sports cars or designer jeans. Now, scientists have figured out why: testosterone.

3 Jul 2018

Anticonvulsants found to be ineffective for low back pain and can have adverse effects

Anticonvulsant drugs are increasingly being used to treat low back pain, but a new study in CMAJ finds they are ineffective and can have adverse effects.

3 Jul 2018

Brain stimulation can reduce a person's intention to commit violent act

Stimulating the prefrontal cortex, the part of the brain responsible for controlling complex ideas and behaviors, can reduce a person's intention to commit a violent act by more than 50 percent, according to research published in the Journal of Neuroscience from the University of Pennsylvania and Nanyang Technological University.

2 Jul 2018

Antioxidants do not improve sperm quality in infertile men, finds study

A large clinical trial has shown that daily antioxidant supplementation among men with infertility does not make a difference to the quality of their sperm.

2 Jul 2018

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson.

2 Jul 2018

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

2 Jul 2018

New medication may treat chemotherapy, radiotherapy-induced oral mucositis

Researchers from the University of Granada have developed new medication which could help to treat and prevent chemotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients.

30 Jun 2018

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

Atlantic Health System is now enrolling patients in four pancreatic cancer clinical trials. Angela Alistar, MD, a nationally known expert on pancreatic cancer, is serving as national Principal Investigator on the first trial and as local PI on three other trials.

30 Jun 2018

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

29 Jun 2018

URI researchers working to develop novel medication to treat alcohol use disorder

Alcohol abuse is among the leading causes of preventable death in the United States, killing more than 88,000 people a year, according to the Centers for Disease Control.

28 Jun 2018

Consuming dark chocolate has no significant effect on woman's muscle recovery

The various health benefits from consuming dark chocolate are highly researched with claims that the antioxidants it contains can help people recover from a tough workout. But research from a University of Huddersfield student, studying Sports and Exercise Nutrition, has concluded it has no significant effect on a woman's muscle recovery post-exercise, posing a need for further research.

28 Jun 2018

Worldwide study to examine new treatments for IgA nephropathy

A patient from Birmingham is the first person to be recruited into a new worldwide study to test new treatments for a potentially life-threatening kidney condition called IgA nephropathy.

28 Jun 2018

Placebo News and Research

Neurotransmitter responsible for brain arousal plays vital role in early sensory perceptions

Human trial identifies common blood pressure medication as safe, effective therapy for diabetes

Step towards an HIV/AIDS vaccine

Study offers new hope for people with disabling Dupuytren's disease

Violent tendencies could be curbed by brain stimulation

Study finds link between testosterone and men's preference for status goods

Antioxidants do not improve sperm quality

Preventive treatment for recurrent pregnancy loss proved ineffective in large study

Testosterone has measurable effect on a man's preference for brands

Anticonvulsants found to be ineffective for low back pain and can have adverse effects

Brain stimulation can reduce a person's intention to commit violent act

Antioxidants do not improve sperm quality in infertile men, finds study

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Psychedelics and their role in treatment of mental health disorders

New medication may treat chemotherapy, radiotherapy-induced oral mucositis

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

URI researchers working to develop novel medication to treat alcohol use disorder

Consuming dark chocolate has no significant effect on woman's muscle recovery

Worldwide study to examine new treatments for IgA nephropathy

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News